Durability of non-nucleotide reverse transcriptase inhibitor-based first-line ART regimens after 7 years of treatment in rural Uganda: A prospective cohort study. (2021)

First Author: Nanfuka M
Attributed to:  Pathogen Genomics, Phenotype and Immunity (PGPI) & Basic Sciences Programme funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1097/md.0000000000025763

PubMed Identifier: 34106606

Publication URI: http://europepmc.org/abstract/MED/34106606

Type: Journal Article/Review

Volume: 100

Parent Publication: Medicine

Issue: 19

ISSN: 0025-7974